A detailed history of Aigh Capital Management LLC transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Aigh Capital Management LLC holds 3,467,275 shares of RNXT stock, worth $3.47 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares
3,467,275
Holding current value
$3.47 Million
% of portfolio
1.85%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 06, 2025

BUY
$0.91 - $1.51 $3.16 Million - $5.24 Million
3,467,275 New
3,467,275 $3.43 Million

Others Institutions Holding RNXT

About RenovoRx, Inc.


  • Ticker RNXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,066,860
  • Market Cap $9.07M
  • Description
  • RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...
More about RNXT
Track This Portfolio

Track Aigh Capital Management LLC Portfolio

Follow Aigh Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aigh Capital Management LLC with notifications on news.